Global Intraoperative Neurophysiological Monitoring Market Trends, Size and Application, By Type (EEG, EMG and Evoked Potential (EP)), Method (Invasive, Non-Invasive and Minimally Invasive), Source (In-house, Outsource and Tele-Health), Procedure (Spinal, Neurovascular, Orthopedic, Otolaryngology Surgery, Urology and others) and Region (North America, Europe, Asia-Pacific and the Middle East & Africa) - Forecast to 2027
ID: MRFR/MED/0258-CR | August 2019 | Region: Global | 114 Pages
1 INTRODUCTION
1.1 DEFINITION 13
1.2 SCOPE OF STUDY 13
1.2.1 RESEARCH OBJECTIVE 13
1.2.2 ASSUMPTIONS & LIMITATIONS 14
1.2.2.1 ASSUMPTIONS 14
1.2.2.2 LIMITATIONS 14
1.3 MARKET STRUCTURE: 14
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS: 15
2.2 PRIMARY RESEARCH 16
2.3 SECONDARY RESEARCH 16
3 MARKET DYNAMICS
3.1 DRIVERS 17
3.1.1 INCREASE IN SURGERY VOLUME 17
3.1.2 IONM TECHNIQUES REDUCE HEALTH CARE COSTS 17
3.1.3 INCREASE IN AWARENESS OF IONM 18
3.1.4 SIGNIFICANT REDUCTION IN MORBIDITY AND MORTALITY RATES 18
3.2 RESTRAINTS 18
3.2.1 SHORTAGE OF THE SKILLED PERSONNEL 18
3.3 OPPORTUNITIES 19
3.4 MACROECONOMIC INDICATORS 19
4 INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE
4.1 ELECTROENCEPHALOGRAPHY 22
4.2 ELECTROMYOGRAPHY 22
4.3 EVOKED POTENTIALS 23
5 INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE
5.1 SPINAL 27
5.2 NEUROVASCULAR 27
5.3 ORTHOPEDIC 29
5.4 OTOLARYNGOLOGY SURGERY 30
5.5 UROLOGY 31
6 INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS
6.1 INVASIVE 34
6.2 NON INVASIVE 34
6.3 MINIMALLY INVASIVE 35
7 INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE
7.1 IN-HOUSE 39
7.2 OUTSOURCED 39
7.3 TELE-HEALTH 41
8 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY REGION
8.1 NORTH AMERICA 43
INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE
INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE
INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS
INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE
8.2 EUROPE 53
INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE
INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE
INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS
INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE
8.3 ASIA-PACIFIC 71
INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE
INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE
INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS
INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE
8.4 MIDDLE EAST & AFRICA 84
INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE
INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE
INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS
INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE
9 COMPANY PROFILE
9.1 ACCURATE MONITORING LLC 93
9.1.1 OVERVIEW 93
9.1.2 PRODUCT OVERVIEW 93
9.1.3 FINANCIALS 93
9.1.4 KEY DEVELOPMENTS 93
9.2 ARGOS NEUROMONITORING LP 94
9.2.1 OVERVIEW 94
9.2.2 PRODUCT OVERVIEW 94
9.2.3 FINANCIALS 94
9.2.4 KEY DEVELOPMENTS 94
9.3 CADWELL LABORATORIES INC. 95
9.3.1 OVERVIEW 95
9.3.2 PRODUCT OVERVIEW 95
9.3.3 FINANCIALS 95
9.3.4 KEY DEVELOPMENTS 95
9.4 COMPUTATIONAL DIAGNOSTICS INC. 96
9.4.1 OVERVIEW 96
9.4.2 PRODUCT OVERVIEW 96
9.4.3 FINANCIALS 96
9.4.4 KEY DEVELOPMENTS 96
9.5 EMOTIV 97
9.5.1 OVERVIEW 97
9.5.2 PRODUCT OVERVIEW 97
9.5.3 FINANCIALS 97
9.5.4 KEY DEVELOPMENTS 98
9.6 INOMED MEDIZINTECHNIK GMBH 99
9.6.1 OVERVIEW 99
9.6.3 FINANCIALS 99
9.6.4 KEY DEVELOPMENTS 99
9.7 INTRANERVE 100
9.7.1 OVERVIEW 100
9.7.3 FINANCIALS 100
9.7.4 KEY DEVELOPMENTS 100
9.8 MEDTRONIC 101
9.8.1 OVERVIEW 101
9.8.2 PRODUCT OVERVIEW 101
9.8.4 KEY DEVELOPMENTS 102
9.9 MEDSURANT HOLDINGS (ADVANCED MEDICAL RESOURCES) 103
9.9.1 OVERVIEW 103
9.9.2 PRODUCT OVERVIEW 103
9.9.3 FINANCIALS 103
9.9.4 KEY DEVELOPMENTS 103
9.10 NATUS MEDICAL INCORPORATED 104
9.10.1 OVERVIEW 104
9.10.2 PRODUCT OVERVIEW 104
9.10.3 FINANCIALS 104
9.10.4 KEY DEVELOPMENTS 104
9.11 NEURO ALERT 105
9.11.1 OVERVIEW 105
9.11.3 FINANCIALS 105
9.11.4 KEY DEVELOPMENTS 105
9.12 NEUROMONITORING TECHNOLOGIES, INC. 106
9.12.1 OVERVIEW 106
9.12.2 PRODUCT OVERVIEW 106
9.12.3 FINANCIALS 106
9.12.4 KEY DEVELOPMENTS 106
9.13 NEUROSENTINEL LLC 107
9.13.1 OVERVIEW 107
9.13.2 PRODUCT OVERVIEW 107
9.13.3 FINANCIALS 107
9.13.4 KEY DEVELOPMENTS 107
9.14 NUVASIVE 108
9.14.1 OVERVIEW 108
9.14.2 PRODUCT OVERVIEW 108
9.14.3 FINANCIALS 108
9.14.4 KEY DEVELOPMENTS 109
9.15 PROCIRCA 110
9.15.1 OVERVIEW 110
9.15.2 PRODUCT OVERVIEW 110
9.15.3 FINANCIALS 110
9.15.4 KEY DEVELOPMENTS 110
9.16 PROPEP SURGICAL 111
9.16.1 OVERVIEW 111
9.16.2 PRODUCT OVERVIEW 111
9.16.3 FINANCIALS 111
9.16.4 KEY DEVELOPMENTS 111
9.17 SPECIALTYCARE 112
9.17.1 OVERVIEW 112
9.17.2 PRODUCT OVERVIEW 112
9.17.3 FINANCIALS 112
9.17.4 KEY DEVELOPMENTS 112
9.18 SENTIENT MEDICAL SYSTEMS 113
9.18.1 OVERVIEW 113
9.18.2 PRODUCT OVERVIEW 113
9.18.3 FINANCIALS 113
9.18.4 KEY DEVELOPMENTS 113
10 LIST OF TABLES
TABLE 1 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2020–2027 (USD MILLION) 21
TABLE 2 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET: ELECTROENCEPHALOGRAPHY, BY REGION, 2020–2027 (USD MILLION) 22
TABLE 3 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET: ELECTROMYOGRAPHY, BY REGION, 2020–2027 (USD MILLION) 23
TABLE 4 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET: EVOKED POTENTIALS, BY REGION, 2020–2027 (USD MILLION) 24
TABLE 5 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 26
TABLE 6 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET: SPINAL, BY REGION, 2020–2027 (USD MILLION) 27
TABLE 7 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET: NEUROVASCULAR, BY REGION, 2020–2027 (USD MILLION) 28
TABLE 11 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2020–2027 (USD MILLION) 33
TABLE 12 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, INVASIVE, 2020–2027 (USD MILLION) 34
TABLE 13 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, NON INVASIVE, 2020–2027 (USD MILLION) 35
TABLE 14 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, MINIMALLY INVASIVE, 2020–2027 (USD MILLION) 35
TABLE 15 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2020–2027 (USD MILLION) 38
TABLE 16 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, IN-HOUSE, 2020–2027 (USD MILLION) 39
TABLE 17 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, OUTSOURCED, 2020–2027 (USD MILLION) 40
TABLE 18 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, TELE-HEALTH, 2020–2027 (USD MILLION) 41
TABLE 19 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION) 42
TABLE 20 NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY COUNTRY (%) 43
TABLE 21 NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 44
TABLE 22 NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE 44
TABLE 23 NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2020–2027 (USD MILLION) 45
TABLE 24 NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 46
TABLE 25 NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2020–2027 (USD MILLION) 47
TABLE 26 NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2020–2027 (USD MILLION) 48
TABLE 27 US INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2020–2027 (USD MILLION) 48
TABLE 28 US INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 49
TABLE 29 US INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2020–2027 (USD MILLION) 49
TABLE 30 US INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2020–2027 (USD MILLION) 50
TABLE 31 CANADA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2020–2027 (USD MILLION) 50
TABLE 32 CANADA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 51
TABLE 33 CANADA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2020–2027 (USD MILLION) 51
TABLE 34 CANADA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2020–2027 (USD MILLION) 52
TABLE 35 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 54
TABLE 36 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2020–2027 (USD MILLION) 55
TABLE 37 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 56
TABLE 38 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2020–2027 (USD MILLION) 57
TABLE 39 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2020–2027 (USD MILLION) 58
TABLE 40 GERMANY INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2020–2027 (USD MILLION) 59
TABLE 41 GERMANY INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 59
TABLE 42 GERMANY INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2020–2027 (USD MILLION) 60
TABLE 43 GERMANY INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2020–2027 (USD MILLION) 60
TABLE 44 FRANCE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2020–2027 (USD MILLION) 61
TABLE 45 FRANCE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 61
TABLE 46 FRANCE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2020–2027 (USD MILLION) 62
TABLE 47 FRANCE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2020–2027 (USD MILLION) 62
TABLE 48 UK INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2020–2027 (USD MILLION) 63
TABLE 49 UK INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 63
TABLE 50 UK INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2020–2027 (USD MILLION) 64
TABLE 51 UK INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2020–2027 (USD MILLION) 64
TABLE 52 ITALY INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2020–2027 (USD MILLION) 65
TABLE 53 ITALY INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 65
TABLE 54 ITALY INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2020–2027 (USD MILLION) 66
TABLE 55 ITALY INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2020–2027 (USD MILLION) 66
TABLE 56 SPAIN INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2020–2027 (USD MILLION) 67
TABLE 57 SPAIN INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 67
TABLE 58 SPAIN INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2020–2027 (USD MILLION) 68
TABLE 59 SPAIN INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2020–2027 (USD MILLION) 68
TABLE 60 EASTERN EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2020–2027 (USD MILLION) 69
TABLE 61 EASTERN EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 69
TABLE 62 EASTERN EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2020–2027 (USD MILLION) 70
TABLE 63 EASTERN EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2020–2027 (USD MILLION) 70
TABLE 64 ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 71
TABLE 65 ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2020–2027 (USD MILLION) 72
TABLE 66 ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 73
TABLE 67 ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2020–2027 (USD MILLION) 74
TABLE 68 ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2020–2027 (USD MILLION) 75
TABLE 69 JAPAN INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2020–2027 (USD MILLION) 76
TABLE 70 JAPAN INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 76
TABLE 71 JAPAN INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2020–2027 (USD MILLION) 77
TABLE 72 JAPAN INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2020–2027 (USD MILLION) 77
TABLE 73 CHINA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2020–2027 (USD MILLION) 78
TABLE 74 CHINA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 78
TABLE 75 CHINA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2020–2027 (USD MILLION) 79
TABLE 76 CHINA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2020–2027 (USD MILLION) 79
TABLE 77 INDIA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2020–2027 (USD MILLION) 80
TABLE 78 INDIA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 80
TABLE 79 INDIA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2020–2027 (USD MILLION) 81
TABLE 80 INDIA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2020–2027 (USD MILLION) 81
TABLE 81 SOUTH KOREA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2020- 2027 (USD MILLION) 82
TABLE 82 SOUTH KOREA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 82
TABLE 83 SOUTH KOREA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2020–2027 (USD MILLION) 83
TABLE 84 SOUTH KOREA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2020–2027 (USD MILLION) 83
TABLE 85 MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION) 84
TABLE 86 MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2020–2027 (USD MILLION) 85
TABLE 87 MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 86
TABLE 88 MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2020–2027 (USD MILLION) 87
TABLE 89 MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2020–2027 (USD MILLION) 88
TABLE 90 MIDDLE EAST INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2020–2027 (USD MILLION) 89
TABLE 91 MIDDLE EAST INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 89
TABLE 92 MIDDLE EAST INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2020–2027 (USD MILLION) 90
TABLE 93 MIDDLE EAST INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2020–2027 (USD MILLION) 90
TABLE 94 AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2020–2027 (USD MILLION) 91
TABLE 95 AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 91
TABLE 96 AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2020–2027 (USD MILLION) 92
TABLE 97 AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2020–2027 (USD MILLION) 92
11 LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS 15
FIGURE 2 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE 21
FIGURE 3 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE 26
FIGURE 4 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS 33
FIGURE 5 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE 38
FIGURE 6 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY REGION 42
FIGURE 7 NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE 45
FIGURE 8 NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS 46
FIGURE 9 NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE 47
FIGURE 10 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY COUNTRY (%) 53
FIGURE 11 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE 55
FIGURE 12 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE 56
FIGURE 13 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS 57
FIGURE 14 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE 58
FIGURE 15 ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY COUNTRY (%) 71
FIGURE 16 ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE 72
FIGURE 17 ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE 73
FIGURE 18 ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS 74
FIGURE 19 ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE 75
FIGURE 20 MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY REGION (%) 84
FIGURE 21 MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE 85
FIGURE 22 MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE 86
FIGURE 23 MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS 87
FIGURE 24 MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE 88
Global Intraoperative Neurophysiological Monitoring Market
The Intraoperative Neurophysiological Monitoring Market is estimated to grow USD 3,125.7 Million at a CAGR of 8.9% from 2021-2028.
$3,125.7 Million
Market Size
8.9%
CAGR
North America
Dominating Region
2021-2028
Forecast Period
Segmentation
Key Players
- Cadwell Laboratories (US)
- IntraNerve (US)
- NeuroMonitoring Technologies (US)
- ProPep Surgical (US)
- Sentient Medical Systems (US)
- Accurate Monitoring LLC (US)
- Natus Medical Incorporated (US)
- NuVasive (US)
- Medsurant Holdings (US)
- Inomed Medizintechnik GmbH (Germany)
Drivers
- Increasing number of patients with several diseases
- Increasing demands of surgical procedures
Intraoperative Neurophysiological Monitoring Market Overview
The Intraoperative Neurophysiological Monitoring Market is estimated to grow at a CAGR of 8.9%. It is estimated that the market value will further touch up to USD 3,125.7 Million by the forecast period 2021-2028. Hence, the market will have a prominent growth due to several drivers and opportunities.
The IONM or intraoperative neurophysiological monitoring program is basically a technique that is used for monitoring different neural pathways during surgical procedures. This procedure is essential in eliminating any high risk that can cause during vascular surgeries, peripheral nerve, orthopedic, and neurosurgical. Along with that, it also helps to detect any injuries before they further evolve into a life-threatening disease.
COVID-19 Analysis of Intraoperative Neurophysiological Monitoring Market
With the spread of COVID-19 disease, the healthcare and business sector was highly disrupted. Governments across the world introduced a lockdown to control the spread. It further led to the financial disruption that largely hampered the availability of skilled laborers and the supply chain. Moreover, with the notable developments in vaccines and removal of lockdown, the Intraoperative Neurophysiological Monitoring Market is expected to regain its growth in the upcoming years.
Intraoperative Neurophysiological Monitoring Market Dynamics
Market Drivers
The major drivers such as the increasing number of patients with several diseases since the previous years will promote the Intraoperative Neurophysiological Monitoring Market. Along with that, the increasing demands of surgical procedures for cardiovascular, orthopedic, genitourinary, ENt, and spinal will fuel the market growth.
Restraints
The high prices for intraoperative neurophysiological monitoring programs are a significant restraint for the market growth. Also, the low awareness regarding the system will hamper the market growth during the forecast period.
Opportunities
The growing developments by the key players in the Intraoperative Neurophysiological Monitoring Market will offer new development opportunities. Also, the increasing geriatric population and early detection of diseases will boost the market in the upcoming years. Hence, the market will have significant growth in the forecast period.
Challenges
The low awareness for the Intraoperative Neurophysiological Monitoring Program among var6ious regions can pose a challenge for the market growth. Along with that, the high costs for surgeries as well as the low availability of skilled professionals will reduce the market growth for the forecast period.
Cumulative Analysis
The Compound Annual Growth Rate (CAGR) of the Intraoperative Neurophysiological Monitoring Market is projected to grow at 8.9%. According to the MRFR analysis, the value of the market will reach up to USD 3,125.7 Million by the end of the forecast period 2021-2028. The growing development of new techniques and equipment will lead to significant growth.
Value Chain Analysis
The increasing developments for the Intraoperative Neurophysiological Monitoring Program and increasing demand for surgeries for better treatment will improve the value chain of the market. Along with that, the lower risks for complications with the help of the monitoring will also develop the value chain in the forthcoming years.
Global Intraoperative Neurophysiological Monitoring Market Share, by Region, 2016 (%)
Market Segmentations
The Intraoperative Neurophysiological Monitoring Market segment is divided into methods, type, source, and surgical procedure. On the basis of procedure, the market is divided into neurovascular, surgery, urology, otolaryngology surgery, orthopedic, and others.
On the basis of methods, the segment is divided into minimally invasive, non-invasive, and invasive procedures. The invasive sub-segment held the largest share in 2015 with a 61.3% CAGR.
On the basis of source, the market is divided into telehealth, outsourced, and in-house. Previously, the in-house sub-segments held the largest market share in 2015 with 59.8%.
On the basis of type, the market is segmented into evoked potentials, electroencephalography, and electromyography.
Regional Analysis
On the basis of region, the Intraoperative Neurophysiological Monitoring Market is segmented into Europe, North America, Asia-Pacific, and the Middle East and Africa. In the year, North America held the largest share in the market with revenue of USD 714.5 Million. It is due to the use of monitoring techniques of intraoperative neurophysiology in major countries such as Canada and the US.
After that, Europe will hold the second-largest share in the market. The growing support and availability of the best healthcare services in this region are fuelling the market growth. Also, the increase in the purchase of insurance policies in the countries such as the UK, Italy, Germany, France, etc. will further boost the Intraoperative Neurophysiological Monitoring Market growth.
However, the rising awareness of intraoperative neurophysiological monitoring programs in the Asia-Pacific region will have a huge impact. Countries such as India, Japan, and China will further lead to merge as the fastest growing regions in the Intraoperative Neurophysiological Monitoring Market.
Also, the growth in the Middle East and Africa will be limited as compared to other regions. The low availability of essential drugs and equipment is the major cause. However, the Intraoperative Neurophysiological Monitoring Market will have a steady and substantial growth in this region.
Intraoperative Neurophysiological Monitoring Market Competitive Landscape
The intraoperative neurophysiological monitoring neurologist reading companies play a major role in propelling the market growth. They do acquisitions, mergers, collaborations new ventures, product launches to expand their business portfolio and market growth. These are some key players in the Intraoperative Neurophysiological Monitoring Market.
- Cadwell Laboratories (US)
- IntraNerve (US)
- NeuroMonitoring Technologies (US)
- ProPep Surgical (US)
- Sentient Medical Systems (US)
- Accurate Monitoring LLC (US)
- Natus Medical Incorporated (US)
- NuVasive (US)
- Medsurant Holdings (US)
- Inomed Medizintechnik GmbH (Germany)
- Argos Neuromonitoring LP (US)
- UPMC Procirca (US)
- Sentient Medical Systems (US)
- Medtronik Specialty(US)
- Nihon Kohden Corporation (Japan)
- EMOTIV (Australia)
Recent Developments
- Medtronic in year 2016 announced the acquisition of a company named Bellco. This acquisition will lead Medtronic to add dialysis treatment for its business of renal care.
- Alphatec Holding in the year 2019 announced the clearance for “Automated SafeOp neuromonitoring system” by FDA. It helps to detect any nerve injury and monitoring.
- Natus Medical in the year 2016 announced the acquisition of NeuroQuest. This acquisition was aimed to promote the company to become a major provider.
Report Overview
The overview of the intraoperative neurophysiological monitoring industry report is as follows.
- Market Overview
- COVID-19 Analysis
- Dynamics of the Market
- Value Chain Analysis
- Market Segmentation
- Regional Analysis
- Competitive Analysis
- Recent Development
Report Score and Segmentation
- Study Period- 2021-2028
- Base Year-2021
- Forecast Period- 2021-2028
- Historical Period-2017-2020
The report score of the Intraoperative Neurophysiological Monitoring Market is to provide insight about the major market developments, opportunities, challenges, etc. It also gives information about the key players and their strategies for business expansion. The information provided in this report is collected from secondary and primary sources.
Segmentation
- By Surgical Procedure
- Orthopedic
- Urology
- Spinal
- Neurovascular
- Otolaryngology Surgery
- By Type
- Electroencephalography
- Evoked Potentials
- Electromyography
- By Methods
- Outsourced
- In-House
- Tele-Health
- By Region
- Asia-Pacific
- North America
- Europe
- The Middle East and Africa
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | USD 3,125.7 Million |
| CAGR | 8.9% |
| Base Year | 2019 |
| Forecast Period | 2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Method, Source, Procedure |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Accurate Monitoring LLC (US), Argos Neuromonitoring LP (US), Cadwell Laboratories Inc. (US), Computational Diagnostics Inc. (Pennsylvania), EMOTIV (California), Inomed Medizintechnik GmbH (Germany), IntraNerve (US), Medtronic (US), Medsurant Holdings (US), Natus Medical Incorporated (US), Neuro Alert (US), NeuroMonitoring Technologies, Inc (US), NeuroSentinel LLC (US), NuVasive(California), Procirca(US), ProPep Surgical(US), SpecialtyCare (US), and Sentient Medical Systems (US) |
| Key Market Opportunities | Macroeconomic indicators |
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
The Intraoperative Neurophysiological Monitoring Market valuation would be USD 3125.7 million.
The projected CAGR would be 8.9% during the forecast period.
The invasive segment was leading the market.
The in-house segment had the charge in 2020.
North America has the edge in leading the market.
